- Trials with a EudraCT protocol (44,334)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging : Frühwald MC, Rickert CH, O'Dorisio MS, Madsen M, Warmuth-Metz M, Khanna G, Paulus W, Kühl J, Jürgens H, Schneider P, Müller HL; Clin Cancer Res. 2004 May 1;10(9):2997-3006 |
| Active substance: (111In) INDIUM CHLORIDE/PENTETREOTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21232 |
| Study title: Patients with seasonal allergic rhinitis, conjunctivitis and possobly asthma symptoms so far only statistical analysis, Publication sheduled. Age of patients: 5 - 79 Years |
| Active substance: 158 Rye |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39753 |
| Study title: Abacavir pharmacokinetics during chronic therapy in HIV-1 infected adolescents and young adults |
| Active substance: abacavir |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41628 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Abropernol (tablets) [AWB-AT] |
| Active substance: Abropernol - Tabletten |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39760 |
| Study title: Retrospective survey for documentation of appllication and dosage of Abropernol N (tablets) in children < 12 years of age [Bef-014] |
| Active substance: Abropernol - Tabletten |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39761 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Abropernol (tablets) [AWB-AT] |
| Active substance: Abropernol N |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39762 |
| Study title: |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_Rating D_Gryzewski N_1982_publication.pdf |
| View full study record |
| Document reference: 46891 |
| Study title: ACARBOSE (BAY G 5421) IN INSULIN-DEPENDENT DIABETES - THE EFFECT ON THE DAILY BLOOD-GLUCOSE PROFILE AND ON THE INSULINCONSUMPTION BY AN ARTIFICIAL PANCREAS (STUDY 0160)(PH-9873) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0160_study_synopsis.pdf |
| View full study record |
| Document reference: 46154 |
| Study title: ACARBOSE AS AN ADJUNCT IN THE MANAGEMENT OF JUVENILE ONSET DIABETESACARBOSE AS AN ADJUNCT IN THE MANAGEMENT OF JUVENILE ONSET DIABETES |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_Bartsocas CS_1982_publication.pdf |
| View full study record |
| Document reference: 46889 |
| Study title: Assessment of efficacy and tolerability of Acarbose in children under 16 years |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_9981_study_synopsis.pdf |
| View full study record |
| Document reference: 46160 |
| Study title: Clinical Study on the Efficacy and Tolerability of Acarbose (BAY g 5421) Compared with Placeboin Diabetic Children on Conventional Insulin Treatment, in Particular with Observation of the Glycemic Control Index ( PH-24820 ) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0665_study_synopsis.pdf |
| View full study record |
| Document reference: 46158 |
| Study title: Clinical Study to Investigate the Efficacy and Tolerability of Acarbose (BAY g 5421) Versus Placebo in Diabetic Children (PH 23433) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0634_study_synopsis.pdf |
| View full study record |
| Document reference: 46155 |
| Study title: Double-Blind, Cross-Over Clinical Study at a Single Centre to Compare Acarbose (BAY g 5421) with Placebo in Respect of Efficacy and Tolerability in Patients with Cystic Fibrosis and Pathological Glucose Tolerance (Pilot Study)(PH-26068) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0696_study_synopsis.pdf |
| View full study record |
| Document reference: 46159 |
| Study title: Guillet J, Blanquet P, Guillet G, Mollard S, Massicot P, Maleville J. The use of technetium Tc 99m medronate scintigraphy as a prognostic guide in childhood dermatomyositis. Arch Dermatol. 1981 Aug;117(8):451. No abstract available. Guillet J, Blanquet P, Guillet G, Mollard S, Massicot P, Maleville J. The use of technetium Tc 99m medronate scintigraphy as a prognostic guide in childhood dermatomyositis. Arch Dermatol. 1981 Aug;117(8):451. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44115 |
| Study title: NON RANDOMISED FOLLW-UP STUDY WITH ACARBOSE-TREATMENT AND PRE- AND AFTER-TREATMENT WITH PLACEBO IN DIABETIC CHILDREN (TYPE I) STUDY 0428 (PH 14352) |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0428_study_synopsis.pdf |
| View full study record |
| Document reference: 46156 |
| Study title: The effect of acarbose (Bay G 5421) on the insulin consumption of children treated with insulin. |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_0221_study_synopsis.pdf |
| View full study record |
| Document reference: 46157 |
| Study title: The modification of sucrose absorption by acarboseThe modification of sucrose absorption by acarbose |
| Active substance: ACARBOSE |
| Study summary document link (including results): Bayer Pharma_Acarbose_Rating D_1982_publication.pdf |
| View full study record |
| Document reference: 46890 |
| Study title: Blockers and hypoglycaemia (assesment of cadioselective and intrinsic sympathometic properties in relation to severity of hypoglycaemia - No author - 1984 (Current Therapeutic Research 36, n° 2, p. 361-373) ; - Publication in Documentation clinique du dossier d'AMM du 30/10/1987 - |
| Active substance: ACEBUTOLOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46182 |
| Study title: Clinical and echocardiographic (echo) long-term follow-up of children with severe hypertension (HT) - Loirat C. et al. - No date (Hopital Bretonneau, INSERM U 120, Paris) ; - Publication in Documentation clinique du dossier d'AMM du 30/10/1987 - |
| Active substance: ACEBUTOLOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46183 |
| Study title: Clinical pharmacology and therapeutic utilization of anti-hypertensive agents in children - Mirkin B.L., Sinaiko - 1977 In : (New M.I., Levine L.S. Juvenile hypertension, pp. 195-218. New-York, Raven Press.) - Publication in expertise clinique pour le dossier français de demande d'extension des indications thérapeutiques de Sectral 200mg comprimés, au traitement de l'hypertension artérielle de l'enfant - Pr Broyer - 14/06/1983 - |
| Active substance: ACEBUTOLOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46184 |
